Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1970 2
1971 1
1972 3
1973 3
1975 6
1976 4
1977 4
1978 7
1979 5
1980 5
1981 8
1982 5
1983 5
1984 5
1985 5
1986 3
1987 5
1988 5
1989 7
1990 13
1991 11
1992 12
1993 14
1994 9
1995 13
1996 9
1997 7
1998 17
1999 20
2000 16
2001 14
2002 17
2003 18
2004 21
2005 25
2006 25
2007 23
2008 24
2009 21
2010 21
2011 31
2012 38
2013 27
2014 28
2015 39
2016 38
2017 35
2018 36
2019 33
2020 30
2021 50
2022 66
2023 59
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

895 results

Results by year

Filters applied: . Clear all
Page 1
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT. Fanouriakis A, et al. Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27. Ann Rheum Dis. 2020. PMID: 32220834
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (LN). METHODS: Following the EULAR standardised operating procedures, a systematic literature review was performed. ...The target of therapy is complete respons …
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (LN). METHODS: Following th …
Lupus Podocytopathy: An Overview.
Oliva-Damaso N, Payan J, Oliva-Damaso E, Pereda T, Bomback AS. Oliva-Damaso N, et al. Adv Chronic Kidney Dis. 2019 Sep;26(5):369-375. doi: 10.1053/j.ackd.2019.08.011. Adv Chronic Kidney Dis. 2019. PMID: 31733721 Free PMC article. Review.
In systemic lupus erythematosus, nephrotic-range proteinuria typically signals the presence of a proliferative lupus nephritis (class III/IV) and/or membranous lupus nephritis (class V, with or without concomitant class III or IV lesions) …
In systemic lupus erythematosus, nephrotic-range proteinuria typically signals the presence of a proliferative lupus nephri …
The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021.
Anders HJ, Loutan J, Bruchfeld A, Fernández-Juárez GM, Floege J, Goumenos D, Turkmen K, van Kooten C, Frangou E, Stevens KI, Kronbichler A, Segelmark M, Tesar V. Anders HJ, et al. Nephrol Dial Transplant. 2023 Feb 28;38(3):551-561. doi: 10.1093/ndt/gfab351. Nephrol Dial Transplant. 2023. PMID: 34888694
In 2019 and 2021, the European League for Rheumatism (EULAR) jointly with the European Renal Association (ERA) and the Kidney Disease: Improving Global Outcomes (KDIGO), respectively, released updated guidelines on the management of lupus nephritis (LN). The Immunol …
In 2019 and 2021, the European League for Rheumatism (EULAR) jointly with the European Renal Association (ERA) and the Kidney Disease: Impro …
Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways.
Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabothu S, Izmirly P, Clancy R, Belmont HM, Koenigsberg M, Mokrzycki M, Rominieki H, Graham JA, Rocca JP, Bornkamp N, Jordan N, Schulte E, Wu M, Pullman J, Slowikowski K, Raychaudhuri S, Guthridge J, James J, Buyon J, Tuschl T, Putterman C; Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium. Der E, et al. Nat Immunol. 2019 Jul;20(7):915-927. doi: 10.1038/s41590-019-0386-1. Epub 2019 May 20. Nat Immunol. 2019. PMID: 31110316 Free PMC article.
The molecular and cellular processes that lead to renal damage and to the heterogeneity of lupus nephritis (LN) are not well understood. We applied single-cell RNA sequencing (scRNA-seq) to renal biopsies from patients with LN and evaluated skin biopsies as a potent …
The molecular and cellular processes that lead to renal damage and to the heterogeneity of lupus nephritis (LN) are not well u …
Telitacicept for autoimmune nephropathy.
Cai J, Gao D, Liu D, Liu Z. Cai J, et al. Front Immunol. 2023 Jun 5;14:1169084. doi: 10.3389/fimmu.2023.1169084. eCollection 2023. Front Immunol. 2023. PMID: 37342346 Free PMC article. Review.
BAFF/APRIL overexpression has been identified in several autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, IgA nephropathy, etc. Telitacicept, a novel fully human TACI-Fc fusion protein that binds both BAFF and APRIL, was approved in China in …
BAFF/APRIL overexpression has been identified in several autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematos …
Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies.
Al-Adhoubi NK, Bystrom J. Al-Adhoubi NK, et al. Lupus. 2020 Apr;29(4):355-363. doi: 10.1177/0961203320903798. Epub 2020 Feb 9. Lupus. 2020. PMID: 32036761 Free PMC article. Review.
The etiology is not completely understood but many patients develop diffuse alveolar hemorrhage concomitant with lupus nephritis, suggesting immune complex-driven pathology. Biopsy studies have identified both cases with capillaritis and a bland non-inflammatory phe …
The etiology is not completely understood but many patients develop diffuse alveolar hemorrhage concomitant with lupus nephritis …
Treatment of proliferative and membranous lupus nephritis: review of key clinical trials.
Alshayeb H, Wall BM, Gosmanova EO. Alshayeb H, et al. Am J Med Sci. 2012 Jan;343(1):86-90. doi: 10.1097/MAJ.0b013e31821996ca. Am J Med Sci. 2012. PMID: 21685786 Review.
Lupus nephritis (LN) is a common complication of systemic lupus erythematosus (SLE), which is associated with significant morbidity and mortality. ...The authors review available treatment options for proliferative and membranous LN and summariz …
Lupus nephritis (LN) is a common complication of systemic lupus erythematosus (SLE), which is associated with significa …
Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
Chen K, Deng Y, Shang S, Tang L, Li Q, Bai X, Chen X. Chen K, et al. Biomed Pharmacother. 2022 Sep;153:113433. doi: 10.1016/j.biopha.2022.113433. Epub 2022 Jul 26. Biomed Pharmacother. 2022. PMID: 36076550 Free article.
BACKGROUND: Lupus nephritis (LN) is the most common complication of systemic lupus erythematosus (SLE), and the abnormal activation of the alternative complement pathway is associated with the pathogenesis of LN. As an inhibitor of complement factor B (CFB) i …
BACKGROUND: Lupus nephritis (LN) is the most common complication of systemic lupus erythematosus (SLE), and the abnorma …
Membranous lupus nephritis.
Austin HA, Illei GG. Austin HA, et al. Lupus. 2005;14(1):65-71. doi: 10.1191/0961203305lu2062oa. Lupus. 2005. PMID: 15732291 Review.
Membranous lupus nephritis (MLN) represents about 20% of clinically significant renal disease in lupus. ...Our assumptions about the underlying mechanisms are based on the combination of extrapolations from idiopathic membranous nephritis …
Membranous lupus nephritis (MLN) represents about 20% of clinically significant renal disease in lupus. ...Our a …
Membranous Lupus Nephritis: A Clinical Review.
Almaani S, Parikh SV. Almaani S, et al. Adv Chronic Kidney Dis. 2019 Sep;26(5):393-403. doi: 10.1053/j.ackd.2019.08.009. Adv Chronic Kidney Dis. 2019. PMID: 31733724 Review.
Membranous lupus nephritis (MLN) (Class V lupus nephritis [LN]) is a distinct form of LN defined by the presence of subepithelial immune complex deposits seen on kidney biopsy. ...The clinical presentation, management, and prognosis of MLN diffe …
Membranous lupus nephritis (MLN) (Class V lupus nephritis [LN]) is a distinct form of LN defined by the p …
895 results